AzTrials
AzTrials

Low Back PainNCT07866690

Pain Neuroscience Education and Neuromuscular Exercise in Individuals With Chronic Low Back Pain and Central Sensitization

A study testing Pain Neuroscience Education and Neuromuscular Exercise in people with Low Back Pain and Chronic Low Back Pain, run by Izmir Katip Celebi University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

The goal of this randomized controlled study is to evaluate the effectiveness of pain neuroscience education (PNE) combined with neuromuscular exercises (NME) in individuals with chronic low back pain and central sensitization, and to compare the effects of this combined intervention with NME alone. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
Pain Neuroscience Education and Neuromuscular Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteTurkey (Türkiye)
Study dates
Oct 2026to Apr 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-60 years
  • Low back pain lasting for at least 3 months
  • Low back pain as the primary complaint
  • Central Sensitization Inventory (CSI) score ≥28
  • Ability to read and write in Turkish
  • Willingness to participate in the study

Who cannot join

  • History of spinal surgery
  • Presence of serious comorbidities (neurological, neuromuscular, cardiovascular, psychiatric conditions)
  • Presence of tumoral conditions
  • Presence of vestibular system disorders
  • Pregnancy
  • Having received physiotherapy within the previous 6 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Izmir Katip Celebi University

    Izmir

    Sevinç Akdeniz, +90 535 077 53 46, sevinc.akdeniiz@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: Effectiveness of Pain Neuroscience Education and Neuromuscular Exercises in Individuals With Chronic Low Back Pain and Central Sensitization: A Randomized Controlled Trial

The goal of this randomized controlled study is to evaluate the effectiveness of pain neuroscience education (PNE) combined with neuromuscular exercises (NME) in individuals with chronic low back pain and central sensitization, and to compare the effects of this combined intervention with NME alone.

The main questions it aims to answer are:

Read more
  • Does PNE combined with NME (PNE+NME) affect pain and functional outcomes in individuals with chronic low back pain and central sensitization?
  • Does NME alone affect pain and functional outcomes in individuals with chronic low back pain and central sensitization?
  • Does adding PNE to NME affect pain and functional outcomes compared with NME alone?

Researchers will evaluate changes in pain and functional outcomes from baseline to post-intervention in both the PNE+NME and NME groups. Changes in outcomes will then be compared between the two groups to determine whether adding PNE to NME affects pain and functional outcomes compared with NME alone.

Participants will:

  • Be randomly assigned to either the PNE+NME group or the NME group.
  • Participate in the assigned intervention for 8 weeks, with 2 sessions per week.
  • Complete outcome assessments at baseline and after the 8-week intervention.
Read the detailed description

Chronic low back pain (CLBP) is a common musculoskeletal condition that can lead to persistent pain, poor functional and psychosocial outcomes. Central sensitization (CS) is present in a subgroup of individuals with CLBP and may contribute to poorer outcomes and greater clinical complexity.

Pain neuroscience education (PNE) aims to improve individuals' understanding of pain mechanisms and modify maladaptive pain-related beliefs. Neuromuscular exercises (NME) aim to improve motor control, muscle function, balance, coordination, and physical function.

This study will investigate the effectiveness of pain neuroscience education (PNE) combined with neuromuscular exercises (NME) in individuals with chronic low back pain and central sensitization and compare the effects of this combined intervention with NME alone.

After eligibility is confirmed and written informed consent is obtained, participants will be randomly assigned to either the NME group or the PNE+NME group. Both groups will participate in an 8-week exercise program with two sessions per week. The PNE+NME group will receive PNE in addition to NME.

At baseline, sociodemographic characteristics, including age, sex, height, weight, body mass index, occupation, medical history, and family history, and health-related habits, including smoking, alcohol consumption, and exercise habits, will be recorded.

The following outcomes will be assessed at baseline and after the 8-week intervention: central sensitization using the Central Sensitization Inventory; pain intensity using the Visual Analog Scale; pressure pain threshold using a pressure algometer; conditioned pain modulation; temporal summation; pain neuroscience knowledge using the Pain Neurophysiology Questionnaire; kinesiophobia using the Tampa Scale for Kinesiophobia; pain catastrophizing using the Pain Catastrophizing Scale; patient-reported physical function using the Oswestry Disability Index; performance-based physical function using the 30-Second Sit-to-Stand Test; body awareness using the Fremantle Back Awareness Questionnaire; spinal structure and mobility using the Hocoma-Valedo®Shape; trunk muscle endurance using the McGill protocol; balance using the ProKin 252 (Tecnobody); and sleep quality using the Single-Item Sleep Quality Scale.

Being tested
Pain Neuroscience Education, Neuromuscular Exercise
Keywords
pain neuroscience education, neuromuscular exercise
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain Neuroscience EducationBehavioural

    Participants will receive pain neuroscience education (PNE) and neuromuscular exercise (NME) twice weekly for 8 weeks. Each session will last approximately 30-40 minutes.

  • Neuromuscular ExerciseBehavioural

    Participants will receive neuromuscular exercise (NME) twice weekly for 8 weeks. Each session will last approximately 30-40 minutes.

Study groups in NCT07866690
Study groupRoleWhat they receive
PNE+NMEExperimentalParticipants will receive pain neuroscience education (PNE) and neuromuscular exercise (NME).
Receives: Behavioral: Pain Neuroscience Education; Behavioral: Neuromuscular Exercise
NMEActive comparatorParticipants will receive neuromuscular exercise (NME).
Receives: Behavioral: Neuromuscular Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Pain intensity at rest, during activity, and at night will be assessed using a 100-mm Visual Analog Scale (VAS), ranging from 0 mm (no pain) to 100 mm (worst imaginable pain). Higher scores indicate greater pain intensity.

    Measured: From enrollment to the end of intervention at 8 weeks

Secondary outcomes (14)
  1. Central sensitization

    The Central Sensitization Inventory (CSI) will be used to assess central sensitization symptoms. Part A consists of 25 items scored on a 5-point Likert scale, yielding a total score of 0-100. Higher scores indicate more severe symptoms.

    Measured: From enrollment to the end of intervention at 8 weeks

  2. Pressure pain threshold

    Pressure pain threshold (PPT) will be measured using a pressure algometer at the thumbnail of the dominant hand and the L5-S1 intervertebral region. A 1-cm² probe will be applied perpendicular to the skin at a rate of 0.5 kg/s until pain is first perceived. Three measurements will be taken at 30-second intervals at each site, and the mean will be recorded.

    Measured: From enrollment to the end of intervention at 8 weeks

  3. Conditioned pain modulation

    Conditioned Pain Modulation (CPM) will be assessed using an ischemic conditioning stimulus induced by cuff inflation to 260 mmHg on the non-dominant arm, combined with wrist exercises using 1 kg for women and 2 kg for men. Exercise will continue for up to 45 repetitions or until arm pain reaches 7 out of 10. PPT will be measured three times at the thumbnail and L5-S1 region before and immediately after conditioning. CPM will be calculated as the difference between post- and pre-conditioning PPT values.

    Measured: From enrollment to the end of intervention at 8 weeks

  4. Temporal summation

    Temporal Summation (TS) will be assessed using a pressure algometer with a 1 cm² probe. Ten consecutive pressure stimuli will be applied at the PPT level to the previously tested sites, with 1-second intervals between stimuli. Pain intensity after the first and tenth stimuli will be rated using a 100-mm VAS. The TS score will be calculated as the difference between the tenth and first VAS scores (post-pre).

    Measured: From enrollment to the end of intervention at 8 weeks

  5. Pain neuroscience knowledge

    Revised Neurophysiology of Pain Questionnaire (RNPQ) assesses knowledge of pain neurophysiology and consists of 12 items. Correct answers receive 1 point, while incorrect and "undecided" responses receive 0 points. Total scores range from 0 to 12, with higher scores indicating greater knowledge of pain neurophysiology.

    Measured: From enrollment to the end of intervention at 8 weeks

  6. Kinesiophobia

    Tampa Scale for Kinesiophobia (TSK) assesses fear of movement and consists of 17 items rated on a 4-point Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). Items 4, 8, 12, and 16 are reverse-scored before calculating the total score, which ranges from 17 to 68. Higher scores indicate greater kinesiophobia.

    Measured: From enrollment to the end of intervention at 8 weeks

  7. Pain catastrophizing

    Pain Catastrophizing Scale (PCS) assesses negative thoughts and feelings related to pain and consists of 13 items rated on a 5-point scale from 0 (not at all) to 4 (all the time). Total scores range from 0 to 52, with higher scores indicating greater pain catastrophizing.

    Measured: From enrollment to the end of intervention at 8 weeks

  8. Body awareness

    Fremantle Back Awareness Questionnaire (FreBAQ) assesses perceptual body awareness of the lower back and consists of 9 items covering neglect-like symptoms, reduced proprioceptive acuity, and perceived body shape and size. Items are rated on a 5-point Likert scale from 0 (never) to 4 (always), yielding a total score of 0-36. Higher scores indicate greater disturbances in back-specific body awareness.

    Measured: From enrollment to the end of intervention at 8 weeks

  9. Disability

    Oswestry Disability Index (ODI) assesses disability related to low back pain and consists of 10 sections. Each section is scored from 0 to 5, yielding a total score of 0-50. The total score may be multiplied by two to express disability as a percentage (0-100%). Higher scores indicate greater disability.

    Measured: From enrollment to the end of intervention at 8 weeks

  10. Performance-based physical function

    30-Second Sit-to-Stand Test (30 s- STS) assesses functional lower-extremity performance. Participants sit in a chair with their feet flat on the floor and arms crossed over the chest. They are instructed to perform as many sit-to-stand repetitions as possible within 30 seconds. The number of completed repetitions is recorded, with higher scores indicating better functional performance.

    Measured: From enrollment to the end of intervention at 8 weeks

  11. Spinal structure and mobility

    Spinal posture and mobility will be assessed using the computer-assisted, non-invasive Hocoma-Valedo®Shape device (Idiag, Fehraltorf, Switzerland). Assessments will be performed with participants standing, with the spinous processes from C7 to S3 marked using a pen. Measurements will be obtained in upright standing, maximum trunk flexion, maximum trunk extension, and maximum right and left lateral flexion positions. The device will be moved along the spine from C7 to S3, tracking the marked spinous processes. Thoracic, lumbar, sacral, and inclination angles will be calculated using the device software. Spinal mobility will be calculated as the difference between maximum flexion and extension in the sagittal plane and between maximum right and left lateral flexion in the frontal plane.

    Measured: From enrollment to the end of intervention at 8 weeks

  12. Trunk muscle endurance

    Trunk muscle endurance will be assessed using the McGill test battery, consisting of trunk flexor, right and left lateral trunk, and trunk extensor endurance tests. The duration for which each position is maintained will be recorded in seconds, with longer times indicating greater trunk muscle endurance.

    Measured: From enrollment to the end of intervention at 8 weeks

  13. Balance

    Balance will be assessed using the ProKin 252 system (Tecnobody, Dalmine, Italy), including static balance with eyes open and closed and limits of stability. Static balance will be assessed over 30 seconds, recording anteroposterior and mediolateral sway (mm) and the balance index (mm²). Limits of stability will be assessed by weight shifting in eight directions, with results expressed as percentages.

    Measured: From enrollment to the end of intervention at 8 weeks

  14. Sleep quality

    Sleep quality will be assessed using the Single-Item Sleep Quality Scale, a self-administered visual analog scale ranging from 0 (terrible) to 10 (excellent), evaluating overall sleep quality over the previous seven days. Higher scores indicate better sleep quality.

    Measured: From enrollment to the end of intervention at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionApr 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07866690
Sponsor's protocol ID
0811
Status last verified
Oct 2026
First submitted
4 Oct 2026
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in